• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK; IN VITRO DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK; IN VITRO DIAGNOSTIC Back to Search Results
Catalog Number 1912997
Device Problems Low Readings (2460); Device Operates Differently Than Expected (2913)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/02/2017
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that lower than expected vitros tsh results were observed when processing samples drawn on different days obtained from one patient on a vitros 5600 integrated system.The likely assignable cause of the event is an interferent causing the lower than expected vitros tsh results.As per the ortho medical safety officer, the patient has consistently low tsh but normal ft4, given that this patient takes 10 mg/day biotin, it is very likely the lower than normal tsh results were due to biotin interference, and the impact to the tsh results could be dependent on the biotin level in the patient¿s circulation at the time of the draw.Per the tsh instructions for use, ortho has not quantified the interfering effect of biotin on the tsh assay at biotin concentrations >0.5 ug/dl.However, on 14 february 2018 ortho issued customer letter ¿information on how biotin may affect specific vitros microwell assays¿ to alert customers of the effect high-dose biotin supplements have on some vitros immunodiagnostics products (microwell assays) such as the vitros tsh assay.The vitros tsh assay includes the use of streptavidin-biotin in the design which may be susceptible to biotin interference.Therefore, the lower than expected vitros tsh results obtained is likely caused by biotin interference.There is no evidence that a vitros tsh reagent issue or a vitros 5600 system issue contributed to the lower than expected vitros tsh results.
 
Event Description
A customer observed consistently lower than expected vitros tsh results obtained from multiple sample draws from the same patient.The vitros tsh results were all considered hyperthyroid when corresponding vitros ft4 results obtained from the same samples were all considered euthyroid.The vitros tsh and ft4 results from each sample are summarized below.(b)(6).The true tsh value for each sample draw is unknown, however as the vitros tsh values are consistently below the reference interval (hyperthyroid) and the vitros ft4 results are consistently within the reference interval (euthyroid), ortho as conservatively decided to report this event.A lower than expected tsh result of the magnitude described above may lead to inappropriate medical action if not detected.It is unknown if the lower than expected, vitros tsh results were reported from the laboratory.However, ortho was not made aware of any allegation of patient harm as a result of this event.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK
Type of Device
IN VITRO DIAGNOSTIC
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key7382921
MDR Text Key104155946
Report Number3007111389-2018-00047
Device Sequence Number1
Product Code JLW
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 03/29/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/29/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/29/2018
Device Catalogue Number1912997
Device Lot Number5550
Other Device ID Number10758750000227
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Date Manufacturer Received03/01/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/25/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-